β-Arrestin 2 is required for B1 receptor-dependent post-translational activation of inducible nitric oxide synthase

FASEB Journal

Volumn 24, Issue 7, 2010, Pages 2475-2483

  Kuhr, Frank K ^a   Zhang, Yongkang ^a   Brovkovych, Viktor ^a   Skidgel, Randal A ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Endothelial cells; Extracellular signal regulated kinase; G protein coupled receptor; Inflammation; Kinins

Indexed keywords

BETA ARRESTIN 2; BRADYKININ B1 RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ANALYSIS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ARRESTINS; CELL LINE; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INFLAMMATION; LUNG; NITRIC OXIDE SYNTHASE TYPE II; RECEPTOR, BRADYKININ B1;

EID: 77954431122     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-148783     Document Type: Article

References (53)

1. Kubes, P. (1995) Nitric oxide affects microvascular permeability in the intact and inflamed vasculature. Microcirculation 2, 235-244
2. Schubert, W., Frank, P. G., Woodman, S. E., Hyogo, H., Cohen, D. E., Chow, C. W., and Lisanti, M. P. (2002) Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice. J. Biol. Chem. 277, 40091-40098
3. Predescu, D., Predescu, S., Shimizu, J., Miyawaki-Shimizu, K., and Malik, A. B. (2005) Constitutive eNOS-derived nitric oxide is a determinant of endothelial junctional integrity. Am. J. Physiol. Lung Cell. Mol. Physiol. 289, L371-L381
4. Papapetropoulos, A., Rudic, R. D., and Sessa, W. C. (1999) Molecular control of nitric oxide synthases in the cardiovascular system. Cardiovasc. Res. 43, 509-520
5. Marrero, M. B., Venema, V. J., Ju, H., He, H., Liang, H., Caldwell, R. B., and Venema, R. C. (1999) Endothelial nitric oxide synthase interactions with G protein-coupled receptors. Biochem. J. 343, 335-340 (Pubitemid 29511765)
6. Ju, H., Venema, V. J., Marrero, M. B., and Venema, R. C. (1998) Inhibitory interactions of the bradykinin B2 receptor with endothelial nitric-oxide synthase. J. Biol. Chem. 273, 24025-24029
7. Golser, R., Gorren, A. C., Leber, A., Andrew, P., Habisch, H. J., Werner, E. R., Schmidt, K., Venema, R. C., and Mayer, B. (2000) Interaction of endothelial and neuronal nitric-oxide synthases with the bradykinin B2 receptor. Binding of an inhibitory peptide to the oxygenase domain blocks uncoupled NADPH oxidation. J. Biol. Chem. 275, 5291-5296
8. Geiger, M., Stone, A., Mason, S. N., Oldham, K. T., and Guice, K. S. (1997) Differential nitric oxide production by microvascular and macrovascular endothelial cells. Am. J. Physiol. Lung Physiol 273, L275-L281
9. Ignjatovic, T., Stanisavljevic, S., Brovkovych, V., Skidgel, R. A., and Erdös, E. G. (2004) Kinin B1 receptors stimulate nitric oxide production in endothelial cells: Signaling pathways activated by angiotensin I-converting enzyme inhibitors and peptide ligands. Mol. Pharmacol. 66, 1310-1316
10. Zhang, Y., Brovkovych, V., Brovkovych, S., Tan, F., Lee, B. S., Sharma, T., and Skidgel, R. A. (2007) Dynamic receptor-dependent activation of inducible nitric-oxide synthase by ERK-mediated phosphorylation of Ser745. J. Biol. Chem. 282, 32453-32461
11. Kleinert, H., Pautz, A., Linker, K., and Schwarz, P. M. (2004) Regulation of the expression of inducible nitric oxide synthase. Eur. J. Pharmacol. 500, 255-266
12. Alderton, W. K., Cooper, C. E., and Knowles, R. G. (2001) Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357, 593-615 (Pubitemid 32735142)
13. Knowles, R. G., and Moncada, S. (1994) Nitric oxide synthases in mammals. Biochem. J. 298, 249-258
14. Brovkovych, V., Zhang, Y., Brovkovych, S., Minshall, R. D., and Skidgel, R. A. (2009) A novel pathway for receptor-mediated post-translational activation of inducible nitric oxide synthase. [E-pub ahead of print] J. Cell. Mol. Med. doi: 10.1111/j.1582-4934.2009.00992.x
15. DeWire, S. M., Ahn, S., Lefkowitz, R. J., and Shenoy, S. K. (2007) β-Arrestins and cell signaling. Annu. Rev. Physiol. 69, 483-510
16. Lefkowitz, R. J., and Shenoy, S. K. (2005) Transduction of receptor signals by β-arrestins. Science 308, 512-517
17. Ozawa, K., Whalen, E. J., Nelson, C. D., Mu, Y., Hess, D. T., Lefkowitz, R. J., and Stamler, J. S. (2008) S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking. Mol. Cell 31, 395-405
18. Sangsree, S., Brovkovych, V., Minshall, R. D., and Skidgel, R. A. (2003) Kininase I-type carboxypeptidases enhance nitric oxide production in endothelial cells by generating bradykinin B1 receptor agonists. Am. J. Physiol. Heart Circ. Physiol. 284, H1959-H1968
19. Liu, J., Ernst, S. A., Gladycheva, S. E., Lee, Y. Y., Lentz, S. I., Ho, C. S., Li, Q., and Stuenkel, E. L. (2004) Fluorescence resonance energy transfer reports properties of syntaxin1a interaction with Munc1-8-1 in vivo. J. Biol. Chem. 279, 55924-55936
20. Siegel, R. M., Chan, F. K., Zacharias, D. A., Swofford, R., Holmes, K. L., Tsien, R. Y., and Lenardo, M. J. (2000) Measurement of molecular interactions in living cells by fluorescence resonance energy transfer between variants of the green fluorescent protein. Sci. STKE 2000, PL1
21. Ahn, S., Nelson, C. D., Garrison, T. R., Miller, W. E., and Lefkowitz, R. J. (2003) Desensitization, internalization, and signaling functions of beta-arrestins demonstrated by RNA interference. Proc. Natl. Acad. Sci. U. S. A. 100, 1740-1744
22. Ahn, S., Wei, H., Garrison, T. R., and Lefkowitz, R. J. (2004) Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by beta-arrestins 1 and 2. J. Biol. Chem. 279, 7807-7811
23. Brovkovych, V., Stolarczyk, E., Oman, J., Tomboulian, P., and Malinski, T. (1999) Direct electrochemical measurement of nitric oxide in vascular endothelium. J. Pharm. Biomed. Anal. 19, 135-143
24. Stanisavljevic, S., Ignjatovic, T., Deddish, P. A., Brovkovych, V., Zhang, K., Erdös, E. G., and Skidgel, R. A. (2006) Angiotensin I-converting enzyme inhibitors block protein kinase Cε by activating bradykinin B1 receptors in human endothelial cells. J. Pharmacol. Exp. Ther. 316, 1153-1158
25. Ren, X. R., Reiter, E., Ahn, S., Kim, J., Chen, W., and Lefkowitz, R. J. (2005) Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor. Proc. Natl. Acad. Sci. U. S. A. 102, 1448-1453
26. Adomeit, A., Graness, A., Gross, S., Seedorf, K., Wetzker, R., and Liebmann, C. (1999) Bradykinin B(2) receptor-mediated mitogen-activated protein kinase activation in COS-7 cells requires dual signaling via both protein kinase C pathway and epidermal growth factor receptor transactivation. Mol. Cell. Biol. 19, 5289-5297
27. Fulton, D., Gratton, J. P., and Sessa, W. C. (2001) Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J. Pharmacol. Exp. Ther. 299, 818-824
28. Ignarro, L. J., Cirino, G., Casini, A., and Napoli, C. (1999) Nitric oxide as a signaling molecule in the vascular system: an overview. J. Cardiovasc. Pharmacol. 34, 879-886
29. Moncada, S., Palmer, R. M., and Higgs, E. A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142
30. Stuehr, D. J. (1997) Structure-function aspects in the nitric oxide synthases. Annu. Rev. Pharmacol. Toxicol. 37, 339-359
31. Aktan, F. (2004) iNOS-mediated nitric oxide production and its regulation. Life Sci. 75, 639-653 (Pubitemid 38686696)
32. Vodovotz, Y., Kim, P. K., Bagci, E. Z., Ermentrout, G. B., Chow, C. C., Bahar, I., and Billiar, T. R. (2004) Inflammatory modulation of hepatocyte apoptosis by nitric oxide: in vivo, in vitro, and in silico studies. Curr. Mol. Med. 4, 753-762
33. Razavi, H. M., Hamilton, J. A., and Feng, Q. (2005) Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure. Pharmacol. Ther. 106, 147-162
34. Chung, H.-T., Pae, H.-O., Choi, B.-M., Billiar, T. R., and Kim, Y.-M. (2001) Nitric oxide as a bioregulator of apoptosis. Biochem. Biophys. Res. Commun. 282, 1075-1079
35. Choy, J. C., Wang, Y., Tellides, G., and Pober, J. S. (2007) Induction of inducible NO synthase in bystander human T cells increases allogeneic responses in the vasculature. Proc. Natl. Acad. Sci. U. S. A. 104, 1313-1318
36. Hoffman, R. A., Zhang, G., Nussler, N. C., Gleixner, S. L., Ford, H. R., Simmons, R. L., and Watkins, S. C. (1997) Constitutive expression of inducible nitric oxide synthase in the mouse ileal mucosa. Am. J. Physiol. Gastrointest. Physiol. 272, G383-G392
37. Guo, F. H., De Raeve, H. R., Rice, T. W., Stuehr, D. J., Thunnissen, F. B., and Erzurum, S. C. (1995) Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc. Natl. Acad. Sci. U. S. A. 92, 7809-7813
38. Marjanovic, J. A., Stojanovic, A., Brovkovych, V. M., Skidgel, R. A., and Du, X. (2008) Signaling-mediated functional activation of inducible nitric-oxide synthase and its role in stimulating platelet activation. J. Biol. Chem. 283, 28827-28834
39. Brovkovych, V., Gao, X.-P., Ong, E., Brovkovych, S., Brennan, M.-L., Su, X., Hazen, S. L., Malik, A. B., and Skidgel, R. A. (2008) Augmented inducible nitric oxide synthase expression and increased NO production reduce sepsis-induced lung injury and mortality in myeloperoxidase-null mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 295, L96-L103
40. DeFea, K. A., Vaughn, Z. D., O'Bryan, E. M., Nishijima, D., Dery, O., and Bunnett, N. W. (2000) The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta-arrestin-dependent scaffolding complex. Proc. Natl. Acad. Sci. U. S. A. 97, 11086-11091
41. Luttrell, L. M., Roudabush, F. L., Choy, E. W., Miller, W. E., Field, M. E., Pierce, K. L., and Lefkowitz, R. J. (2001) Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc. Natl. Acad. Sci. U. S. A. 98, 2449-2454
42. Shenoy, S. K., Drake, M. T., Nelson, C. D., Houtz, D. A., Xiao, K., Madabushi, S., Reiter, E., Premont, R. T., Lichtarge, O., and Lefkowitz, R. J. (2006) Beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J. Biol. Chem. 281, 1261-1273
43. Tohgo, A., Pierce, K. L., Choy, E. W., Lefkowitz, R. J., and Luttrell, L. M. (2002) Beta-arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J. Biol. Chem. 277, 9429-9436
44. DeFea, K. A., Zalevsky, J., Thoma, M. S., Dery, O., Mullins, R. D., and Bunnett, N. W. (2000) β-Arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J. Cell Biol. 148, 1267-1281
45. Lohse, M. J., Bunemann, M., Hoffmann, C., Vilardaga, J. P., and Nikolaev, V. O. (2007) Monitoring receptor signaling by intramolecular FRET. Curr. Opin. Pharmacol. 7, 547-553
46. Gurevich, V. V., and Gurevich, E. V. (2006) The structural basis of arrestin-mediated regulation of G-protein-coupled receptors. Pharmacol. Ther. 110, 465-502
47. Hess, D. T., Matsumoto, A., Kim, S. O., Marshall, H. E., and Stamler, J. S. (2005) Protein S-nitrosylation: purview and parameters. Nat. Rev. Mol. Cell. Biol. 6, 150-166
48. Ushio-Fukai, M. (2009) Vascular signaling through G protein-coupled receptors: new concepts. Curr. Opin. Nephrol. Hypertens. 18, 153-159
49. Kokkola, T., Savinainen, J. R., Monkkonen, K. S., Retamal, M. D., and Laitinen, J. T. (2005) S-nitrosothiols modulate G protein-coupled receptor signaling in a reversible and highly receptor-specific manner. BMC Cell Biol. 6, 21 (Pubitemid 41357615)
50. Wang, G., Moniri, N. H., Ozawa, K., Stamler, J. S., and Daaka, Y. (2006) Nitric oxide regulates endocytosis by S-nitrosylation of dynamin. Proc. Natl. Acad. Sci. U. S. A. 103, 1295-1300
51. Cao, S., Yao, J., McCabe, T. J., Yao, Q., Katusic, Z. S., Sessa, W. C., and Shah, V. (2001) Direct interaction between endothelial nitric-oxide synthase and dynamin-2. Implications for nitricoxide synthase function. J. Biol. Chem. 276, 14249-14256
52. Whalen, E. J., Foster, M. W., Matsumoto, A., Ozawa, K., Violin, J. D., Que, L. G., Nelson, C. D., Benhar, M., Keys, J. R., Rockman, H. A., Koch, W. J., Daaka, Y., Lefkowitz, R. J., and Stamler, J. S. (2007) Regulation of β-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell 129, 511-522 (Pubitemid 46660966)
53. Leeb-Lundberg, L. M., Marceau, F., Muller-Esterl, W., Pettibone, D. J., and Zuraw, B. L. (2005) International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 57, 27-77